HUGO ID Detailed Result 2578


HUGO ID 2578
Symbol CYBB
Name cytochrome b-245, beta polypeptide (chronic granulomatous disease)
#Occurrence 62
#Paper 2

 


PMID Match String Actual String Score Flanking text Edited by Edit
18219386NOX2Nox23.5Figure 1 Production of ROS by microglial Nox2 during inflammation is amplified by mutant SOD1 binding to Rac1 
18219386NOX2Nox23.5(through through deletion of the gene encoding either Nox1 or Nox2 an increase in survival was seen with Nox2 deletion proving 
18219386NOX2Nox23.5Nox1 or Nox2 an increase in survival was seen with Nox2 deletion proving to be of greater benefit than Nox1 deletion 
18219386NOX2Nox23.5Consistent with progressive microglial activation during disease Nox2 expression was upregulated in SOD1 G93A mice ( 13 14 
18219386NOX2Nox23.5The Nox prototype Nox2 is the phagocytic Nox (also also known as gp91 phox 
18219386NOX2Nox23.5Nox2 contains an NADPH-binding site a FAD-binding site and 4 heme-binding 
18219386NOX2Nox23.5Nox2 is constitutively associated with the transmembrane Nox stabilizing protein p22 
18219386NOX2NOX23.5all Nox family members require the same interacting partners but Nox1 and Nox2 are both p47 phox and Rac dependent ( 
18219386NOX2Nox23.5family members require the same interacting partners but Nox1 and Nox2 are both p47 phox and Rac dependent ( 15 
18219386NOX2Nox23.5This scenario is consistent with protection observed by Nox2 deletion in other models of neurodegeneration in which inflammation has 
18219386NOX2Nox23.5In addition dopaminergic neurons cocultured with microglial cells lacking the Nox2 gene are more resistant to rotenone-induced neuronal death ( 18 
18219386NOX2Nox23.5SOD1 interacts directly with Rac1 but not with the other Nox2 cytosolic regulators ( 20 
18219386NOX2Nox23.5bound Rac1-GTP the form of Rac1 that is recruited to Nox2 upon activation 
18219386NOX2Nox23.5Thus only if SOD1 mutants increase Nox2 activity independently of their metalated state could mutant SOD1_amp_#x02013 enhanced 
18219386NOX2Nox23.5Decreasing ROS production by deleting Nox2 has already proven efficacious in ALS mice ( 13 14 
18219386NOX2Nox23.5and in fact greater than _amp_#x02014 the deletion of the Nox2 gene in SOD1 G93A mice previously reported by the same 
18219386NOX2NOX23.5only the Nox proteins requiring these cytosolic activators which include Nox1 and Nox2 
18219386NOX2Nox23.5Nox proteins requiring these cytosolic activators which include Nox1 and Nox2 
18219386NOX2Nox23.5Although expression of Nox2 by neurons astrocytes and endothelial cells has been reported ( 
18219386NOX2Nox23.5and endothelial cells has been reported ( 15 staining for Nox2 in ALS mice only revealed accumulation in microglial cells ( 
18219386NOX2Nox23.5Of relevance for patients Nox2 upregulation has been reported in spinal cords of sporadic ALS 
18219386NOX2Nox23.5patients with SOD1 mutations generate similar or greater increases in Nox2 activity or expression 
18219386NOX2Nox23.5Two reported studies of ALS mice with a Nox2 deletion reached divergent conclusions one group described downregulation of microglial 
18219386NOX2Nox23.5Mutations altering the activity of Nox2 (or or other subunits of Nox are known to cause 
18219386CGDCGD2.5of Nox are known to cause chronic granulomatous disease (CGD) CGD ( 15 which is characterized by severe and chronic infections 
18219386CGDCGD2.5CGD patients are usually chronically administered antibiotics and IFN-_amp_#x003b3 
18219386NOX2Nox23.5that interaction of metalated SOD1 with Rac1 serves to activate Nox2 and that mutant forms of SOD1 amplify production of ROS 
18219386NOX2Nox23.5mutant forms of SOD1 amplify production of ROS by locking Nox2 in its activated state Harraz and colleagues have advanced a 
16877542gp91 phoxgp91 phox1.0transgenic sod1 g93a mice [c57bl/6j tgn sod1 g93a 1gur dl ] were crossed with gp91 phox deficient mice b6.129s6 cybb tm1din .  
16877542gp91 phoxgp91 phox1.0primer sequences for gp91 phox glial fibrillary acidic protein macrophage antigen complex 1 and gapdh and pcr conditions are presented in supporting text .  
16877542gp91 phoxgp91 phox1.0expression of nadph oxidase in the spinal cord which carries the brunt of the pathology in this als model was determined by analyzing its catalytic subunit gp91 phox .  
16877542gp91 phoxgp91 phox1.0both gp91 phox message and protein contents in whole tissue extracts of spinal cord rose over time in transgenic sod1 g93a mice fig 1 a b d and e in concert with the development of a glial response fig 6 which is p 
16877542gp91 phoxgp91 phox1.0histological evaluation of the spinal cord of symptomatic transgenic sod1 g93a mice showed numerous gp91 phox positive cells primarily in the gray matter of the anterior horn fig 1 g whereas sparse staining was observed in the spinal cord of age matched nontransgenic controls fig 1 f .  
16877542gp91 phoxgp91 phox1.0consistent with nadph oxidase expression by professional phagocytes confocal microscopy demonstrated the colocalization of the gp91 phox subunit with a microglial marker the ricinus communis agglutinin lectin fig 1 h _amp_#x02013; j ; no gp91 phox colocalization was detected with the motor neuron marker nonphosphorylated neurofilament 
16877542gp91 phoxgp91 phox1.0 subunit with a microglial marker the ricinus communis agglutinin lectin fig 1 h _amp_#x02013; j ; no gp91 phox colocalization was detected with the motor neuron marker nonphosphorylated neurofilament heavy chain or with the astrocyte marker glial fibrillary acid protein data not shown .  
16877542gp91 phoxgp91 phox1.0in contrast in symptomatic transgenic sod1 g93a mice carrying the wild type gp91 phox allele sod g93a /gp91 phox+ spinal cord ethidium fluorescence was intense fig 1 l and coincided anatomically with the areas of gp91 phox expression fig 1 g and microglial activation fig 6 .  
16877542gp91 phoxgp91 phox1.0+ spinal cord ethidium fluorescence was intense fig 1 l and coincided anatomically with the areas of gp91 phox expression fig 1 g and microglial activation fig 6 .  
16877542gp91 phoxgp91 phox1.0symptomatic transgenic sod1 g93a /gp91 phox+ mice but not age matched sod1 g93a /gp91 phox_amp_#x02212; mice had increased levels of spinal cord protein carbonyl adducts compared with nontransgenic controls expressing either wild type or null  
16877542gp91 phoxgp91 phox1.0but not age matched sod1 g93a /gp91 phox_amp_#x02212; mice had increased levels of spinal cord protein carbonyl adducts compared with nontransgenic controls expressing either wild type or null mutant gp91 phox fig 1 n .  
16877542gp91 phoxgp91 phox1.0immunohistochemically the most robust labeling for protein carbonyl adducts occurred in spinal cord sections from sod1 g93a /gp91 phox+ mice at the level of cells with mixed morphology including large motor neurons fig 1 o _amp_#x02013; q .  
16877542gp91 phoxgp91 phox1.0consistent with the mouse data gp91 phox content was low fig 2 a and b and its immunoreactivity was faint in control postmortem spinal cords fig 2 d whereas gp91 phox content was _amp_#x02248;3 fold higher and its immunoreactivity robust in sporadic als spinal cords fig 2 e .  
16877542gp91 phoxgp91 phox1.0in the latter gp91 phox positive cells colocalized with the microglial associated antigen cd68 fig 2 f and were identified in all of the typical als loci of neurodegeneration including the anterior horn and the lateral cort 
16877542gp91 phoxgp91 phox1.0deletion of gp91 phox mitigates the disease phenotype in transgenic sod1 g93a mice.  
16877542gp91 phoxgp91 phox1.0transgenic sod1 g93a /gp91 phox_amp_#x02212; mice reached end stage paralysis defined as a loss of the righting reflex later than their transgenic sod1 g93a /gp91 phox+ counterparts fig 3 a which resulted in a longer lifespan of transgenic sod1 g93a /gp91 phox_amp_#x02212; mice log rank test = 15.3; p _amp_#x0003c; 0.001 .  
16877542gp91 phoxgp91 phox1.0compared with end stage transgenic sod1 g93a /gp91 phox+ mice age matched transgenic sod1 g93a /gp91 phox_amp_#x02212; mice had _amp_#x02248;50% more anterior horn motor neurons in the spinal cord fig 3 b _amp_#x02013; e and myelinated axons in the fifth  
16877542gp91 phoxgp91 phox1.0spinal cord microgliosis evidenced by macrophage antigen complex 1 immunostaining and levels of the glial cytokine il 1_amp_#x003b2; did not differ between age matched transgenic sod1 g93a /gp91 phox+ mice and sod1 g93a /gp91 phox_amp_#x02212; mice fig 7 which is published as supporting information on the pnas web site .  
16877542gp91 phoxgp91 phox1.0also not affected by the deficit of gp91 phox were the levels of human sod1 in transgenic sod1 g93a mice fig 7 or the size of muscle fibers in the fibularis and peroneus longus muscles in nontransgenic mice fig 3 t .  
16877542gp91 phoxgp91 phox1.0however protein carbonyl adducts were evident in the _amp_#x003b1; chain of the igf1 tyrosine kinase cognate receptor in the spinal cord of symptomatic transgenic sod1 g93a /gp91 phox+ mice fig 4 a and b ; similar results were obtained for the _amp_#x003b2; chain of igf1 receptor data not shown .  
16877542gp91 phoxgp91 phox1.0however there were fewer phospho igf1 receptor immunoreactive cells in spinal cord sections from symptomatic transgenic sod1 g93a /gp91 phox+ mice than from age matched sod1 g93a /gp91 phox_amp_#x02212; mice fig 4 c _amp_#x02013; e .  
16877542gp91 phoxgp91 phox1.0 as fewer cells that were immunoreactive for a downstream target of akt phospho bad fig 4 h _amp_#x02013; j and smaller phospho bad:total bad ratios fig 4 k and l in symptomatic transgenic sod1 g93a /gp91 phox+ mice compared with their age matched sod1 g93a /gp91 phox_amp_#x02212; counterparts.  
16877542gp91 phoxgp91 phox1.0these data further support the idea that oxidative modification of igf1 receptor in symptomatic transgenic sod1 g93a /gp91 phox+ mice is associated with a range of molecular perturbations.  
16877542gp91 phoxgp91 phox1.0germane to the molecular basis of this deleterious effect on motor neurons is our finding that virtually all spinal cord microglial cells express the gp91 phox subunit of the oxidant producing enzyme nadph oxidase fig 1 .  
16877542gp91 phoxgp91 phox1.0agreeing with the fact that in nonactivated phagocytes nadph oxidase is quiescent 7 gp91 phox positive cells in spinal cords from 1 to 4 month old nontransgenic mice had a morphology of resting microglia and did not seem to produce ros figs 1 and 6 .  
16877542gp91 phoxgp91 phox1.0our results also show that abrogation of the gp91 phox subunit of nadph oxidase in transgenic sod1 g93a mice eliminates the production of microglial derived ros fig 1 m and importantly prolongs survival and retards neurodegeneration in this als model fig 
16877542gp91 phoxgp91 phox1.0deletion of gp91 phox in transgenic sod1 g93a mice did not alter the spinal cord microglial response or the expression of human sod1 in transgenic sod1 g93a mice fig 7 which is a known determinant of disease severity in t 
16877542gp91 phoxgp91 phox1.0however the magnitude of benefit afforded by gp91 phox deletion in transgenic sod1 g93a mice argues that targeting neuroinflammation by inhibiting just one of its mediators such as nadph oxidase may not be sufficient to produce robust and lasting neuropr 
16877542gp91 phoxgp91 phox1.0nevertheless whether transgenic sod1 g93a mice carrying the gp91 phox null mutation reach end stage paralysis later and exhibit an attenuated neurodegenerative process because of some effects at the skeletal muscle level is an interesting possibility that cannot be exc 
16877542gp91 phoxgp91 phox1.0 a _amp_#x02013; e spinal cord gp91 phox mrna a and d and protein b and e in 1 month old asymptomatic to 4 month old end stage transgenic sod1 more ...  
16877542gp91 phoxgp91 phox1.0 a and b immunoblots and bar graph for gp91 phox using spinal cord extracts from six normal controls and six age matched als patients.  
16877542gp91 phoxgp91 phox1.0deletion of gp91 phox increases lifespan and lessens neurodegeneration in transgenic sod1 g93a mice.  
16877542gp91 phoxgp91 phox1.0 a survival comparison of transgenic sod1 g93a /gp91 phox+ mice red 122.0 _amp_#x000b1; 1.7 days; n = 19 and transgenic sod1 g93a /gp91 phox_amp_#x02212; littermates more ...  
18219386gp91 phoxgp91 phox1.0the nox prototype nox2 is the phagocytic nox also known as gp91 phox that generates o 2 _amp_#x02022;_amp_#x02013; not as a byproduct but as a primary function of the enzyme 15 .